Taiwanese hospital to install ZAP Surgical's radiosurgery platform
Kaohsiung Show Chwan Memorial Hospital (KSCH) is set to install ZAP Surgical Systems' ZAP-X Gyroscopic Radiosurgery platform, representing a major step forward in Taiwan's neuro-oncology landscape.
The installation, scheduled for the fourth quarter of 2025, will begin treating patients from the first quarter of 2026.
Part of the Show Chwan Healthcare System, KSCH is a new medical facility in Taiwan.
The hospital is enhancing its neuro-oncology practice with the ZAP-X system, which offers non-invasive treatment for patients with brain tumours and other neurological disorders.
SRS is a non-invasive, painless procedure that treats brain tumours and other head and neck disorders without incisions.
Typically completed in a single outpatient visit, SRS represents a significant departure from traditional open surgery.
Show Chwan Healthcare System president Dr. Min-Ho Huang said: 'SRS is revolutionising the way we treat brain tumours and neurological conditions.
'With the addition of ZAP-X at KSCH, we are reinforcing our commitment to providing world-class, non-invasive treatment solutions to patients in Taiwan and beyond.'
The integration of ZAP-X makes radiosurgery more accessible, removing the requirements for expensive shielded radiation rooms.
The ZAP-X platform uses a modern linear accelerator for radiation generation, avoiding the challenges of managing and replacing Cobalt-60 radioactive isotopes.
The gyroscopic design of the ZAP-X system allows for the precise targeting of tumours from thousands of angles, which helps to protect critical structures, such as the brain stem and optic nerves.
This precision reduces radiation exposure to healthy brain tissue, improving patient safety and preserving cognitive function.
The Show Chwan Healthcare System has traditionally used Cobalt-60 technology for SRS treatments.
The addition of the ZAP-X platform offers an alternative, promising to improve treatment versatility and accuracy.
"Taiwanese hospital to install ZAP Surgical's radiosurgery platform" was originally created and published by Hospital Management, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
a day ago
- Medscape
Small Ear-Wax Sample, Big Diagnostic Clues
A recent BBC report suggests that cerumen, commonly known as earwax, may harbor biomarkers to aid in the diagnosis and monitoring of conditions such as cancer, Alzheimer's disease, and metabolic disorders. Cerumen Profile The primary function of cerumen is to keep the external auditory canal clean and lubricated, preventing invasion by bacteria, fungi, and insects. Beyond this, cerumen may reflect systemic metabolism by concentrating a broader array of compounds than blood, urine, sweat, and tears. Its relative stability allows the accumulated cerumen to provide long-term snapshots of metabolic changes. Disease Associations Researchers have defined genetically determined wet and dry cerumen phenotypes. In the US, Caucasian, African American, and German women with wet cerumen faced roughly four times the risk of dying from breast cancer compared with Japanese and Taiwanese women with dry cerumen. The study found that Japanese women with breast cancer were more likely to carry the wet-cerumen allele than were healthy controls. However, large-scale studies in Germany, Australia, and Italy failed to confirm these associations. A recent analysis reported that patients with Ménière's disease had lower levels of three fatty acids in the cerumen compared with healthy controls — the first biomarker identified for that disorder. In a 2019 study led by Nelson Roberto Antoniosi Filho, PhD (Federal University of Goiás Goiânia in Brazil), researchers analyzed cerumen samples from 52 patients with lymphoma, carcinoma, or leukemia and 50 healthy volunteers, using a method that identifies volatile organic compounds (VOCs). The researchers identified 27 VOCs that served as diagnostic fingerprints for cancer, predicting the cancer status with 100% accuracy. The assay could not distinguish among cancer types, indicating that these VOCs represent a general response to malignant cells. Another investigation by the same group showed that cerumen analysis can detect metabolic disturbances in premalignant stages when cells exhibit dysplastic changes that may lead to cancer but remain nonmalignant, potentially enabling much earlier intervention. The team is also investigating whether metabolic alterations caused by neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease, can be detected in the cerumen. Diagnostic Tool Antoniosi Filho and colleagues proposed that cancer, as a mitochondrial metabolic disorder, releases VOCs that accumulate in cerumen, allowing differentiation between healthy and cancerous individuals via an assay they call the cerumenogram. The aim was to develop a cerumenogram as a diagnostic tool to accurately predict certain cancers from a small cerumen sample. Clinical Adoption Hospital Amaral Carvalho in Jaú, São Paulo — a national reference center for oncology and bone marrow transplantation — has recently implemented cerumenograms for cancer diagnosis and monitoring. Future Directions An April 2025 paper in Scientific Reports by Antoniosi Filho concluded that the cerumenogram could: 1. Identify oncologic risk by detecting premalignant cells before cancer onset, introducing a novel screening modality 2. Show that mitochondrial impairment in premalignant cells — such as hypermetabolic inflammation and dysplasia — produces the same VOC biomarkers as malignant cells, distinct from those in benign lesions, opening new paths for risk management and early intervention 3. Correlate cerumenogram findings with established imaging techniques such as 2-deoxy-2-[fluorine-18] fluoro-D-glucose PET/CT (18F-FDG PET/CT) and gallium-68 PSMA PET/CT, demonstrating alignment with clinical results while offering a noninvasive, lower-cost alternative 4. Monitor treatment response and cancer remission, supporting assessment of therapeutic efficacy and cellular return to normal 5. Confirm metabolic indicators of malignancy to guide clinical decisions alongside imaging and biopsy 6. Drive the development of targeted therapies aimed at metabolites overproduced in malignant conditions. In conclusion, the cerumenogram may serve as a valuable assay for evaluating precancerous indicators, cancer progression, and remission, with the potential to reduce mortality, alleviate patient suffering, and lower disease-related costs. Congratulations to Nelson Roberto Antoniosi Filho, PhD, and his team.
Yahoo
2 days ago
- Yahoo
Nuclear fusion record smashed as German scientists take 'a significant step forward' to near-limitless clean energy
When you buy through links on our articles, Future and its syndication partners may earn a commission. A recently concluded experimental campaign at the Wendelstein 7-X stellarator at the Max Planck Institute for Plasma Physics (IPP) in Greifswald, Germany has smashed previous fusion records and set a new benchmark for reactor performances. Nuclear fusion offers a tantalizing promise of unlimited clean energy. By smashing together isotopes (or different versions) of hydrogen at incredibly high temperatures, the resulting superheated plasma of electrons and ions fuses into heavier atoms, releasing a phenomenal amount of energy in the process. However, while this fusion reaction is self-sustaining under the extraordinary temperatures and pressures within stars, recreating these conditions on Earth is a huge technical challenge — and current reactor concepts still consume more energy than they are able to produce. Stellarators are one of the most promising reactor designs, so named for their mimicry of reactions in the sun. They use powerful external magnets to control the high-energy plasma within a ring-shaped vacuum chamber and maintain a stable, high pressure. Unlike simpler tokamak reactors — which pass a high current through the plasma to generate the required magnetic field — stellarators' external magnets are better at stabilizing the plasma through the fusion reactions, a feature that will ultimately be necessary when translating the technology to commercial power plants. In the recent experiments, the W7-X stellarator outperformed previous benchmarks set by the decommissioned tokamak reactors JT60U in Japan and JET in the UK, especially over how long the plasma can be sustained. Related: Nuclear fusion could be the clean energy of the future Most notably, the international team revealed that the reactor had reached a new record high triple product — a key metric for the success of fusion power generators. The triple product is a combination of the density of particles in the plasma, the temperature required for these particles to fuse, and the energy confinement time (a measure of how well the thermal energy is held by the system). A certain minimum value called the Lawson criterion marks the point at which the reaction produces more energy than it uses and becomes self-sustaining, so a higher triple product indicates a more efficient reaction. "The new record is a tremendous achievement by the international team," said Thomas Klinger, Head of Operations at Wendelstein 7-X and Head of Stellarator Dynamics and Transport at IPP in a statement. "Elevating the triple product to tokamak levels during long plasma pulses marks another important milestone on the way toward a power-plant-capable stellarator." Key to the success of this latest milestone was the development of a new fuel pellet injector that combined continuous refueling of the reactor with pulsed heating to maintain the required plasma temperature. Over a 43-second period, 90 frozen hydrogen pellets were fired into the plasma at up to 2,600 feet (800 metres) per second, roughly the speed of a bullet. Pre-programmed pulses of powerful microwaves heated the plasma, which reached a peak temperature of 30 million degrees C, and this coordination between the microwave pulses and the pellet injection crucially extended how long the plasma could be stably maintained. RELATED STORIES —Physicists solve nuclear fusion mystery with mayonnaise —There's 90,000 tons of nuclear waste in the US. How and where is it stored? —Just a fraction of the hydrogen hidden beneath Earth's surface could power Earth for 200 years, scientists find This same campaign also increased the energy turnover of the reaction to 1.8 gigajoules over a six-minute run, smashing the reactor's previous record of 1.3 gigajoules from February 2023. Energy turnover is a combination of the heating power and plasma duration of a fusion reactor and an indication of the reactor's ability to sustain the high-energy plasma. It is therefore another crucial parameter for future power plant operation. The new value even exceeds the record achieved by the Experimental Advanced Superconducting Tokamak (EAST) in China earlier this year, further evidencing stellarators' potential. "The records of this experimental campaign are much more than mere numbers. They represent a significant step forward in validating the stellarator concept—made possible through outstanding international collaboration," summarized Robert Wolf, Head of Stellarator Heating and Optimization at IPP in statement.
Newsweek
3 days ago
- Newsweek
Gen Z's Trauma Therapy Compared to Millennials, Boomers
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Gen Z may have a reputation for being the weakest generation, but their trauma therapy habits indicate they are not too different from their millennial and Gen-X elders. Baby Boomers, however, show a reluctance to seek help for traumatic experiences. In a new report from Rula Health, Americans' therapy habits were analyzed by generation. Baby Boomers' reluctance for trauma therapy may be defined by their upbringing. "Their reluctance to seek trauma therapy reflects a generation that was told to suck it up, repress everything, and call it strength," Driscoll told Newsweek. Why It Matters Gen Z, which includes those aged roughly from 12 to 28, has been reported as more likely to deal with mental health issues, with some employers and elders seeing them as a "softer" generation. A survey by Talker Research for Traditional Medicinals found that 19 percent of respondents under 18 had taken a mental health day in the past few weeks alone. Meanwhile, 65 percent of Baby Boomers said they had never called in sick due to stress. Additionally, a 2023 Gallup survey found that just 15 percent of Gen Zers reported their mental health as excellent, a substantial drop from the decade before when 52 percent of millennials in the same age range reported their mental health as excellent. Elyssa Thelin, a substance use disorder counselor and art therapist at the Cielo Treatment Center, talks about how people use art as therapy for their feelings and trauma at the Cielo Treatment Center for drug... Elyssa Thelin, a substance use disorder counselor and art therapist at the Cielo Treatment Center, talks about how people use art as therapy for their feelings and trauma at the Cielo Treatment Center for drug addiction rehabilitation and mental health in Portland, Oregon on January 24, 2024. More PATRICK T. FALLON/AFP via Getty Images What To Know When it comes to the generations and trauma therapy, there are fewer differences than one might expect. The new Rula Health report found those aged 18 to 24 (considered older Gen-Zers) sought therapy due to trauma 31.6 percent of the time, with those aged 25 and 34 (oldest of Gen-Z and the younger half of millennials) also seeking help for trauma at 30.8 percent. Even in the older age group of 45 to 54 (Gen-X), 30.1 percent reported they were going to therapy for trauma. The number only significantly dipped off at age 55 to 64 (the oldest of Gen-X and younger Boomers), when only 16.9 percent were in therapy for trauma, and even less, 10.3 percent of those aged 65 and older (Baby Boomers) said they went to therapy due to trauma. This reflects that Baby Boomers are the real outlier when it comes to their views on trauma and therapy, said Bryan Driscoll, an HR consultant who specializes in generational differences. "Their reluctance to seek trauma therapy reflects a generation that was told to suck it up, repress everything, and call it strength," Driscoll told Newsweek. "But unaddressed trauma doesn't go away - it just turns into bad parenting, addiction, rage, and broken families. Boomers don't dodge therapy because they're tougher than younger generations. They dodge therapy because they've been shamed out of it." Relationship therapist Joy Berkheimer, who is also the founder of Joy Collective, echoed this sentiment. "The reluctance among many Boomers to seek therapy reflects deeper cultural, societal, and historical contexts," Berkheimer told Newsweek. "They were raised in a time where mental health stigma was stronger, and seeking help could be seen as a sign of failure or weakness." Across the board, 54 percent of those in therapy were seeking it for help with anxiety, with 52.9 percent going due to depression. A similar rate to those in therapy for trauma (26.8 percent) were seeing a professional for stress or burnout at 33.1 percent. Those aged 45 to 54 reported the highest rates of anxiety and burnout, while those aged 55 to 64 showed the highest rates of depression. What People Are Saying Bryan Driscoll, an HR consultant who specializes in generational differences, told Newsweek: "This data doesn't show Gen Z and other younger generations are weak. It shows they're more self-aware and more willing to confront pain head-on, rather than bury it under a 'just deal with it' mentality. What people too often label as weakness is actually emotional literacy. Older generations were raised to believe therapy was for people who were broken. Gen Z knows it's for people who want to break cycles." Monica Cwynar, a licensed counselor and social worker with Thriveworks, told Newsweek: "Baby boomers (ages 55–64) and older generations show much lower rates of therapy-seeking behavior, particularly at only 16.9 percent. Their lower rate of engagement can reflect a cultural background shaped by different societal norms around mental health, where there has traditionally been a stigma associated with seeking help. Boomers are more likely to emphasize resilience, self-reliance, and the belief that personal struggles should be handled privately, that seeking help is a weakness, resulting in a hesitance to seek external support like therapy." Relationship therapist Joy Berkheimer, also the founder of Joy Collective, told Newsweek: "The data clearly does not support the narrative that Gen Z is 'weaker.' Instead, it shows that all generations are increasingly recognizing the importance of mental health, though their methods and comfort levels differ. What we're witnessing is a shift in cultural norms: more openness, less stigma, and greater access." What Happens Next Berkheimer said on a larger level, Gen Z is breaking down the stigmas around mental health and trauma, which could impact how people engage with therapy moving forward. "This generation is more likely to openly seek therapy, prioritize emotional well-being, and engage in practices that emphasize healing and self-awareness... In contrast, older generations may have been conditioned to view therapy as a last resort or a sign of weakness, often due to cultural and societal taboos rooted in stigma and distrust."
